Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

Two Connecticut high school seniors, Meera Kannan and Gabrielle Bridgewater, have published their study findings, titled ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

Censoring research on how to deliver treatments to those most in need isn’t just nonsensical; it puts lives at risk and ...